| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-105 |
Sentence |
denotes |
Differential effects on light chain amyloid formation depend on mutations and type of glycosaminoglycans. |
| T2 |
106-328 |
Sentence |
denotes |
Amyloid light chain (AL) amyloidosis is a protein misfolding disease where immunoglobulin light chains sample partially folded states that lead to misfolding and amyloid formation, resulting in organ dysfunction and death. |
| T3 |
329-521 |
Sentence |
denotes |
In vivo, amyloid deposits are found in the extracellular space and involve a variety of accessory molecules, such as glycosaminoglycans, one of the main components of the extracellular matrix. |
| T4 |
522-638 |
Sentence |
denotes |
Glycosaminoglycans are a group of negatively charged heteropolysaccharides composed of repeating disaccharide units. |
| T5 |
639-792 |
Sentence |
denotes |
In this study, we investigated the effect of glycosaminoglycans on the kinetics of amyloid fibril formation of three AL cardiac amyloidosis light chains. |
| T6 |
793-896 |
Sentence |
denotes |
These proteins have similar thermodynamic stability but exhibit different kinetics of fibril formation. |
| T7 |
897-995 |
Sentence |
denotes |
We also studied single restorative and reciprocal mutants and wild type germ line control protein. |
| T8 |
996-1202 |
Sentence |
denotes |
We found that the type of glycosaminoglycan has a different effect on the kinetics of fibril formation, and this effect seems to be associated with the natural propensity of each AL protein to form fibrils. |
| T9 |
1203-1414 |
Sentence |
denotes |
Heparan sulfate accelerated AL-12, AL-09, κI Y87H, and AL-103 H92D fibril formation; delayed fibril formation for AL-103; and did not promote any fibril formation for AL-12 R65S, AL-103 delP95aIns, or κI O18/O8. |
| T10 |
1415-1518 |
Sentence |
denotes |
Chondroitin sulfate A, on the other hand, showed a strong fibril formation inhibition for all proteins. |
| T11 |
1519-1890 |
Sentence |
denotes |
We propose that heparan sulfate facilitates the formation of transient amyloidogenic conformations of AL light chains, thereby promoting amyloid formation, whereas chondroitin sulfate A kinetically traps partially unfolded intermediates, and further fibril elongation into fibrils is inhibited, resulting in formation/accumulation of oligomeric/protofibrillar aggregates. |